Verrica PharmaceuticalsVRCA
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 50 institutions reported holding Verrica Pharmaceuticals Inc. (VRCA) in their 13F filings, up 17 from Q3 2025. 21 opened new positions and 5 sold out. The largest holders were Armistice Capital, LLC ($9.3M), Caligan Partners LP ($7.7M) and Affinity Asset Advisors, LLC ($5.9M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Verrica Pharmaceuticals Inc.
- CUSIP
- 92511W207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 21 | $18.5M |
| Exits | 5 | $24K |
All 13F filers, Q3 2025 → Q4 2025: 2,719,637 shares bought and 228,293 shares sold, net +2,491,344 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 50 holders
| Armistice Capital, LLC | 0.23% | Add +75.0% | 1,118,925 | $9.3M |
| Caligan Partners LP | 0.70% | No change | 923,910 | $7.7M |
| Affinity Asset Advisors, LLC | 0.44% | New | 707,338 | $5.9M |
| Velan Capital Investment Management LP | 2.28% | New | 471,559 | $3.9M |
| Stonepine Capital Management, LLC | 2.32% | New | 353,669 | $2.9M |
| Boothbay Fund Management, LLC | 0.06% | No change | 280,734 | $2.3M |
| Kalehua Capital Management LLC | 1.94% | — | 235,779 | $2.0M |
| DAFNA Capital Management LLC | 0.34% | New | 173,451 | $1.4M |
| Vanguard Group Inc. | 0.00% | Reduce -38.6% | 138,194 | $1.1M |
| Two Sigma Investments, LP | 0.00% | New | 118,218 | $982K |
| Jane Street Group, LLC | 0.00% | New | 101,722 | $845K |
| Marshall Wace, LLP | 0.00% | New | 85,173 | $708K |
| Geode Capital Management, LLC | 0.00% | No change | 67,659 | $562K |
| Two Sigma Advisers, LP | 0.00% | New | 44,430 | $369K |
| Squarepoint Ops LLC | 0.00% | New | 33,270 | $276K |
| Sovran Advisors, LLC | 0.02% | Reduce -55.8% | 32,658 | $249K |
| Renaissance Technologies | 0.00% | Reduce -9.6% | 26,400 | $219K |
| Mariner, LLC | 0.00% | Reduce -0.0% | 24,544 | $204K |
| State Street Corp. | 0.00% | Add +14.1% | 23,481 | $195K |
| Millennium Management | 0.00% | Reduce -67.9% | 23,123 | $192K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 22,600 | $188K |
| Morgan Stanley | 0.00% | Add +1.5% | 22,009 | $183K |
| Northern Trust Corp. | 0.00% | Reduce -0.0% | 20,024 | $166K |
| Goldman Sachs Group Inc. | 0.00% | New | 18,621 | $155K |
| HRT Financial LP | 0.00% | New | 17,356 | $144K |
| Legacy Trust | 0.03% | New | 17,234 | $143K |
| Walleye Capital LLC | 0.00% | New | 15,240 | $127K |
| XTX Topco Ltd | 0.00% | New | 14,662 | $122K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 12,000 | $100K |
| Beck Mack & Oliver LLC | 0.00% | New | 12,000 | $100K |
| Quadrature Capital Ltd | 0.00% | New | 11,954 | $99K |
| Man Group plc | 0.00% | New | 11,287 | $94K |
| BlackRock, Inc. | 0.00% | Reduce -7.5% | 5,685 | $47K |
| Bank of America Corp. | 0.00% | Add +5931.9% | 4,343 | $36K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +116.6% | 3,342 | $28K |
| Capital Analysts, LLC | 0.00% | No change | 1,500 | $12K |
| Fortitude Family Office, LLC | 0.00% | New | 608 | $5K |
| Royal Bank of Canada | 0.00% | Reduce -65.6% | 416 | $3K |
| Salomon & Ludwin, LLC | 0.00% | No change | 290 | $3K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 200 | $2K |
| International Assets Investment Management, LLC | 0.00% | New | 175 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -11.3% | 110 | $914 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 102 | $847 |
| JPMorgan Chase & Co. | 0.00% | New | 47 | $391 |
| Optiver Holding B.V. | 0.00% | No change | 31 | $258 |
| UBS Group AG | 0.00% | Reduce -99.9% | 24 | $199 |
| Group One Trading LLC | 0.00% | No change | 3 | $25 |
| MAI Capital Management | 0.00% | No change | 2 | $17 |
| Barclays PLC | 0.00% | No change | 1 | $8 |
| Covestor Ltd | 0.00% | No change | 54 | $0 |
"% of holder's portfolio" is VRCA's weight in each manager's 13F, not the share of Verrica Pharmaceuticals Inc. the manager owns.